Brian Woodfall

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

José Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2007 · 516 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

Adriano Lazzarin, Thomas Campbell, Bonaventura Clotet et al. · The Lancet · 2007 · 392 citations

Medicine, Infectious Diseases, Pharmacology +12

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Christine Katlama, Richard Haubrich, Jacob Lalezari et al. · AIDS · 2009 · 192 citations

Medicine, Pharmacology, Pharmacotherapy +17

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

Johan Vingerhoets, Lotke Tambuyzer, Hilde Azijn et al. · AIDS · 2010 · 185 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Lack of antiviral activity of darunavir against SARS-CoV-2

Sandra De Meyer, Denisa Bojková, Jindřich Činátl et al. · International Journal of Infectious Diseases · 2020 · 137 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15